SCHOTT Pharma AG & Co. KGaA (BIT:1SXP)
Italy
· Delayed Price · Currency is EUR 25.15
-0.40 (-1.57%)
At close: May 7, 2025
BIT:1SXP Cash Flow Statement
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
Net Income | 134.17 | 149.69 | 151.84 | 125.38 | 100.75 | 77.48 |
Depreciation & Amortization | 68.88 | 64.98 | 51.85 | 43.79 | 36.44 | 33.73 |
Loss (Gain) From Sale of Assets | -0.11 | -0.59 | -0.39 | -1.51 | -0.3 | -0.72 |
Asset Writedown & Restructuring Costs | - | - | -5.2 | 11.57 | - | - |
Loss (Gain) From Sale of Investments | -1.49 | -1.36 | -0.69 | - | - | - |
Loss (Gain) on Equity Investments | 2.25 | 4.25 | 2 | - | - | - |
Other Operating Activities | 1.87 | -4.11 | -2.93 | 27.01 | 10.57 | 4.52 |
Change in Accounts Receivable | -13.16 | -16.96 | -32.43 | -35.57 | -18.5 | -19.68 |
Change in Inventory | -13.66 | -3.41 | -15.38 | -30.64 | -19.06 | -12.12 |
Change in Accounts Payable | 3.48 | 8.47 | -3.9 | 29.11 | 0.87 | 14.36 |
Change in Unearned Revenue | -11.88 | 17.48 | 28.63 | 25.42 | 20.67 | 7.14 |
Change in Other Net Operating Assets | 23.03 | 11.13 | 7.42 | -15.59 | -0.97 | 1.13 |
Operating Cash Flow | 183.69 | 225.33 | 181.65 | 182.12 | 132.21 | 104.4 |
Operating Cash Flow Growth | -16.46% | 24.04% | -0.26% | 37.75% | 26.64% | - |
Capital Expenditures | -137.7 | -145.08 | -175.47 | -152.01 | -98.07 | -85.17 |
Sale of Property, Plant & Equipment | 1.13 | 1.51 | 4.78 | 12.36 | 1.21 | 2.84 |
Sale (Purchase) of Intangibles | -0.24 | -0.22 | -0.06 | -0.68 | -0.35 | -0.14 |
Investment in Securities | -1.46 | -2.14 | -0.66 | -1.81 | -1.35 | - |
Other Investing Activities | - | - | - | - | 2.68 | 1.25 |
Investing Cash Flow | -138.28 | -145.93 | -171.41 | -142.14 | -95.89 | -81.22 |
Long-Term Debt Issued | - | - | - | 1.04 | - | 0.65 |
Long-Term Debt Repaid | - | -4.1 | -4.25 | -1.54 | -1.59 | -0.89 |
Net Debt Issued (Repaid) | -5.76 | -4.1 | -4.25 | -0.5 | -1.59 | -0.24 |
Common Dividends Paid | -22.59 | -22.59 | -18.88 | -11.46 | -39.82 | -44.04 |
Other Financing Activities | -19.52 | -51.46 | 11.73 | -30.43 | 13.91 | 29.84 |
Financing Cash Flow | -47.88 | -78.16 | -11.4 | -42.38 | -27.51 | -14.45 |
Foreign Exchange Rate Adjustments | -2.1 | -2.42 | -3.28 | 3.33 | 0.44 | -5.78 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | 0 | - |
Net Cash Flow | -4.56 | -1.18 | -4.44 | 0.94 | 9.25 | 2.95 |
Free Cash Flow | 45.99 | 80.25 | 6.19 | 30.11 | 34.14 | 19.22 |
Free Cash Flow Growth | 26.81% | 1197.51% | -79.46% | -11.80% | 77.60% | - |
Free Cash Flow Margin | 4.82% | 8.38% | 0.69% | 3.67% | 5.26% | 3.29% |
Free Cash Flow Per Share | 0.31 | 0.53 | 0.04 | 0.20 | 0.23 | 0.13 |
Cash Interest Paid | 12.41 | 10.57 | 6.66 | 1.8 | 1.16 | 1.53 |
Cash Income Tax Paid | 28.96 | 29.73 | 31.68 | 29.77 | 21.4 | 15.12 |
Levered Free Cash Flow | -97.54 | -70.46 | 72.63 | -201.87 | -21.3 | - |
Unlevered Free Cash Flow | -88.15 | -62.47 | 76.79 | -200.55 | -20.56 | - |
Change in Net Working Capital | 131.94 | 100.24 | -93.24 | 196.7 | 30.14 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.